IPHARMA is a contract research organization specialized in conducting clinical trials of investigational drugs in the Russian Federation and the EAEU.
-
Drug registration
IPHARMA is a member of ChemRar High-Tech Center group of companies and an accredited partner of Skolkovo Innovation Center.
IPHARMA results
IPHARMA #1 CRO by the number of CTAs in 2020
150+
180+
100
16
820+
17500+
25+
50+
Drug products in clinical pipline
Protocols written
CTA approvals
Clinical trials on COVID-19
Clinical sites
Subjects enrolled
Audits passed
Original medical devices registered
If you would like to report an adverse drug reaction, you can do this
by phone: +7 (495) 276-11-43
e-mail: sae@ipharma.ru
or by filling out the online form on the website.
IPHARMA is now collecting information on Normacor®.
Advantages of working with IPHARMA
1. Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2020.
2. Opportunities for drug localization, investments, and market access.
3. Full cycle of drug development: formulation, batches, QC, preclinical, clinical.
4. Medical and PV expertise with access to top scientists and KOLs.
5. Quality management systems and experienced staff.
IPHARMA contacts
Skolkovo Innovation Center,
Business center "Amalteya",
40, Bolshoy Boulevard, 2 floor, office 77
121205, Moscow, Russia
Tel.: +7 (495) 276-11-43
Fax: +7 (495) 276-11-47
E-mail: info@ipharma.ru
